Tenor Capital Management’s BioPlus Acquisition Corp. Class A Ordinary Shares BIOS Stock Holding History

Tenor Capital Management’s Portfolio BIOS Stock Details BIOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-250,000	Closed	-$2.71M	–	400
2023 Q3	$2.71M	Hold	250,000	–	–	0.06%	144
2023 Q2	$2.66M	Hold	250,000	–	–	0.06%	137
2023 Q1	$2.61M	Hold	250,000	–	–	0.05%	158
2022 Q4	$2.56M	Hold	250,000	–	–	0.06%	192
2022 Q3	$2.51M	Hold	250,000	–	–	0.06%	239
2022 Q2	$2.48M	Hold	250,000	–	–	0.06%	256
2022 Q1	$2.47M	Buy	+250,000	New	+$2.47M	0.05%	262

Tenor Capital Management's BIOS Position: Q4 2023 in Review

Tenor Capital Management sold out of BioPlus Acquisition Corp. Class A Ordinary Shares (BIOS) in Q4 2023, closing a stake of 250,000 shares — an estimated $2.71M sold.

Tenor Capital Management first reported a position in BIOS in Q1 2022 and held it in 7 quarters. The position peaked at $2.71M in Q3 2023. 0 funds tracked by Wall St. Rank hold BIOS as of Q4 2023.

Tenor Capital Management reported no remaining BioPlus Acquisition Corp. Class A Ordinary Shares position as of Q4 2023 after selling out during the quarter.
Tenor Capital Management sold 250,000 BioPlus Acquisition Corp. Class A Ordinary Shares shares in Q4 2023, an estimated $2.71M.
Tenor Capital Management first reported a position in BioPlus Acquisition Corp. Class A Ordinary Shares in Q1 2022 and held it in 7 quarters.
Tenor Capital Management's BioPlus Acquisition Corp. Class A Ordinary Shares position peaked at $2.71M in Q3 2023.
0 funds tracked by Wall St. Rank held BioPlus Acquisition Corp. Class A Ordinary Shares as of Q4 2023.

Based on Tenor Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.